Apollon Formularies PLC - London-based medical cannabis pharmaceutical firm - On Wednesday, said intends to withdraw its shares from trading on the Aquis Growth Market, with the last day of trading expected to be on June 3. ‘The company continues to progress the divestment of its intellectual property, proprietary formulations and other assets associated with its cancer research business to a Canadian company in the same field,’ it says. Apollon adds: ‘There will be no alternative exchange or platform to trade the company’s ordinary shares once withdrawal has taken place, however, the company will explore potential mechanisms for the ongoing sale and purchase of its ordinary shares using platforms tailored to unlisted companies. It has not yet identified such a platform.’

Current stock price: 0.05 pence per share, down 29% on Thursday afternoon in London

12-month change: down 70%

Copyright 2024 Alliance News Ltd. All Rights Reserved.